Cargando…
Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
IMPORTANCE: Despite unprecedented injuries and deaths from prescription opioids, little is known regarding medication coverage policies for the treatment of chronic noncancer pain among US insurers. OBJECTIVE: To assess medication coverage policies for 62 products used to treat low back pain. DESIGN...
Autores principales: | Lin, Dora H., Jones, Christopher M., Compton, Wilson M., Heyward, James, Losby, Jan L., Murimi, Irene B., Baldwin, Grant T., Ballreich, Jeromie M., Thomas, David A., Bicket, Mark, Porter, Linda, Tierce, Jonothan C., Alexander, G. Caleb |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324424/ https://www.ncbi.nlm.nih.gov/pubmed/30646077 http://dx.doi.org/10.1001/jamanetworkopen.2018.0235 |
Ejemplares similares
-
Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers
por: Heyward, James, et al.
Publicado: (2018) -
Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs
por: Murimi-Worstell, Irene B., et al.
Publicado: (2019) -
Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019
por: Plummer, Elizabeth, et al.
Publicado: (2022) -
Coverage of genetic therapies for spinal muscular atrophy across fee-for-service Medicaid programs
por: Ballreich, Jeromie, et al.
Publicado: (2022) -
Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021)